Trial intelligence / Profile preview

Sirolimus Conversion in African American Renal Transplant Recipients

NCT00999258Phase 4Unknown

Sponsor
Temple University
Start
Sep 2009
Primary completion
Jun 2011
Countries
1
01

Overview

Phase 4, randomised, open-label trial of sirolimus in Chronic Allograft Kidney Disease (CKaD), sponsored by Temple University. Status: unknown.

02

Drugs

sirolimus
03

Conditions

Chronic Allograft Kidney Disease (CKaD)

Beyond the preview

Go deeper on NCT00999258.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00999258.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call